Vista Pharmaceuticals Ltd.

View in App
16.49 +0.32 ▲2.0%

01 December 2023, 04:01:00 PM
Volume: 12,205

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vistapharmaceuticals.com
Market Cap 75.07 Cr.
Enterprise Value(EV) 84.33 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.71 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 8.74 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.89 Calculated using Price: 16.49
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 4.55 Cr. 45,524,899 Shares
FaceValue 2
About Vista Pharmaceuticals Ltd.
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

Vista Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Vista Pharmaceuticals Ltd. Performance

View details >>
1 Day
+1.98%
1 Week
-3.96%
1 Month
+14.91%
3 Month
+21.07%
6 Month
+100.85%
1 Year
+117.55%
2 Year
+68.44%
5 Year
-25.05%
10 Year
+438.89%

Vista Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 13.94 7.15 8.97 10.19 3.15 -11.68 -6.43 -2.60 -17.16
Return on Capital Employed (%) 14.16 9.57 8.92 12.42 6.28 -5.20 -5.10 -3.75 -9.85
Return on Assets (%) 7.39 3.15 3.70 4.67 1.78 -7.11 -3.89 -1.70 -10.73

Vista Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 10 11 17 32 36 30 33 35 37 39
Non Curr. Liab. 0 8 5 6 6 5 11 4 3 2
Curr. Liab. 12 7 19 15 11 16 9 13 14 14
Minority Int.
Equity & Liab. 23 26 41 53 53 51 53 52 53 54
Non Curr. Assets 11 10 16 25 29 30 37 29 30 30
Curr. Assets 12 16 26 28 23 21 15 24 24 24
Misc. Exp. not W/O
Total Assets 23 26 41 53 53 51 53 52 53 54

Vista Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 14 15 24 29 31 23 1 0 1 6
Other Income 0 0 0 0 3 4 0 0 0 1
Total Income 14 15 24 29 34 27 1 1 1 7
Total Expenditure -11 -13 -21 -24 -30 -28 -3 -2 -5 -10
PBIDT 3 3 3 6 4 -1 -2 -1 -4 -3
Interest 0 -1 -1 -2 -2 -2 -2 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -2
Taxation 0 0 0 -1 0 0 2 2 0 -2
Exceptional Items
PAT 1 1 1 2 1 -4 -2 -1 -6 -8
Adjusted EPS 1 0 0 1 0 -1 -1 0 -2 -2

Vista Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 -4 -3 3 -5 3 1 -7 -1 -2
Cash Fr. Inv. 0 0 0 -4 -11 -6 -2 0 0 -1
Cash Fr. Finan. 4 3 6 11 1 0 7 1 3
Net Change 0 0 5 -4 -1 -1 0 0 0
Cash & Cash Eqvt 0 0 0 6 2 1 0 0 0 0

Vista Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 36.94 36.94 35.44 35.44 35.44 35.44 35.44 30.51 29.51
Public 63.06 63.06 64.56 64.56 64.56 64.56 64.56 69.49 70.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vista Pharmaceuticals Ltd. Announcements

View details >>
Tue, 28 Nov 2023
Announcement under Regulation 30 (LODR)-Allotment
Kindly take note of the allotment of 6 40 000 equity shares pursuant to the conversion of 6 40 000 warrants issued to others on a private placement basis
Fri, 10 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 10.11.2023
It is hereby informed that the Meeting of the Board of Directors of the Company was held on Friday 10th November 2023.at 04:00 PM and ended at 05:55 PM at the corporate office of the Company.
Fri, 10 Nov 2023
Results Financial Results As Of 30.09.2023.
Copy of unaudited Financial Results for the quarter and half year ended 30.09.2023 along with Limited Review Report is enclosed herewith

Vista Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High

Vista Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Vista Pharmaceuticals Ltd. FAQ's

What is Vista Pharma share price?
Can I buy Vista Pharma shares now?
What is the Market Cap of Vista Pharma?
What are the key metrics to analyse Vista Pharma?
What is the 52 Week High and Low of Vista Pharma?
What is the trend of Vista Pharma share price?